Drug intelligence / Profile preview

r-phenylephrine

Development stage
Unknown
Lead developer
Paragon BioTeck
Modality
Small Molecules
Administration
Oral, Intranasal, Intravenous, Ophthalmic
01

Overview

r-phenylephrine is the dextrorotatory enantiomer of phenylephrine, a **small-molecule sympathomimetic alpha-1 adrenergic receptor agonist** used clinically as a vasoconstrictor and decongestant. The provided sources specifically discuss r-phenylephrine as the desired chiral product of biocatalytic synthesis from 1-(3-hydroxyphenyl)-2-(methylamino) ethanone using engineered or recombinant *Serratia marcescens* short-chain dehydrogenase/reductase systems, rather than as a novel proprietary development program. Pharmacologically, the active therapeutic effect is mediated primarily through stimulation of alpha-1 adrenergic receptors on vascular smooth muscle, producing vasoconstriction; this underlies uses such as nasal decongestion and hemodynamic support depending on formulation and route. The drug is an established pharmaceutical ingredient rather than a combination product, device, supplement, or biologic.

Other names
(R)-phenylephriner-phenylephrine(R)-PE
02

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on r-phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on r-phenylephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call